ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients (ALECSAT-GBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01588769
Recruitment Status : Completed
First Posted : May 1, 2012
Last Update Posted : June 6, 2016
Sponsor:
Information provided by (Responsible Party):
CytoVac A/S

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : April 2013